Legal Opinion
Stuart ex rel. Craven v. American Cyanamid Co.
Court of Appeals for the Second Circuit
Decided September 21, 1998No. 97-9548PublishedCited by 1 opinion
1Opinion of the Court
BACKGROUND
McLAUGHLIN, Circuit J.
Polio is a disease of the central nervous system for which Dr. Jonas Salk developed a vaccine in 1955. The Salk vaccine was an inactivated polio vaccine (“IPV”), derived from a dead polio virus. Although the Salk vaccine dramatically decreased the incidence of polio, it did not eradicate the disease.
While Dr. Salk was developing his IPV which had to be injected, other scientists, notably Dr. Albert Sabin, were working on an oral polio vaccine (“OPV”). Unlike IPV, OPV is produced from a live virus that is attenuated, but not killed, during the production…
2Cases cited31 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Klaxon Co. v. Stentor Electric Manufacturing Co.Supreme Court of the United States · 1941
- Guaranty Trust Co. v. YorkSupreme Court of the United States · 1945
- Guaranty Trust Co. v. YorkSupreme Court of the United States · 1945
- Alexander v. Burroughs Corp.Supreme Court of Louisiana · 1978
26 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Stuart v. American Cyanamid CompanyCourt of Appeals for the Second Circuit · 1998